Year-End Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$60,000

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Report (this page) Feb 13, 2008 $60,000 Replaced
Year-End Report Feb 14, 2008 $60,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Essential use medications and ozone-depleting substances. Nominations to FDA and AHRQ advisory committees,

LobbyistCovered position, as disclosed
JUSTINE COFFEY N/A
JOSEPH M HILL N/A
BRIAN M MEYER N/A

Contacted: Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Requirement to report National Drug Code Number to State Medicaid agencies (provision in Deficit Reduction Act.) H.R. 3090, provision delaying date requiring tamper resistant prescriptions. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management.

LobbyistCovered position, as disclosed
JUSTINE COFFEY N/A
JOSEPH M HILL N/A
BRIAN M MEYER N/A

Contacted: Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; SENATE; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3025 (110th), H.R. 3090 (110th)

Pharmacy PHA

HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisions. S.901, Reauthorization of National Health Service Corps, provisions relating to loan forgiveness programs. Funding for Food and Drug Admnistration. HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR1038, Access to Life Saving Medicine Act, provisions dealing with interchangability. Proposal by FDA for a behind the counter drug category (public meeting and comments). Electronic

LobbyistCovered position, as disclosed
JUSTINE COFFEY N/A
JOSEPH M HILL N/A
BRIAN M MEYER N/A

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Bills named: H.R. 1956 (110th), S. 901 (110th), H.R. 3580 (110th), H.R. 1038 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.